Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages

BioFactors

Volumn 42, Issue 1, 2016, Pages 80-92

  Marengo, Barbara ^a   Bellora, Francesca ^a   Ricciarelli, Roberta ^a   De Ciucis, Chiara ^a   Furfaro, Annalisa ^b   Leardi, Riccardo ^a   Colla, Renata ^a   Pacini, Davide ^c   Traverso, Nicola ^a   Moretta, Alessandro ^a   Pronzato, Maria Adelaide ^a   Bottino, Cristina ^a,b   Domenicotti, Cinzia ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

27 hydroxycholesterol; Atherosclerosis; Cholesterol; Macrophage polarization; Oxysterols

Indexed keywords

26 HYDROXYCHOLESTEROL; ABC TRANSPORTER A1; ALCOHOL; ANTIINFLAMMATORY AGENT; CD204 ANTIGEN; CD36 ANTIGEN; CHOLESTEROL; GELATINASE B; INTERLEUKIN 10; LIVER X RECEPTOR ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; OXYSTEROL; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG; 27-HYDROXYCHOLESTEROL; ABC TRANSPORTER; CHOLESTEROL DERIVATIVE; IL10 PROTEIN, HUMAN; LIVER X RECEPTOR; MSR1 PROTEIN, HUMAN; ORPHAN NUCLEAR RECEPTOR; SCAVENGER RECEPTOR A;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL POLARITY; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FOAM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC;

ANTIGENS, CD36; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL POLARITY; CELL SURVIVAL; CHOLESTEROL; ETHANOL; HUMANS; HYDROXYCHOLESTEROLS; INTERLEUKIN-10; LIVER X RECEPTORS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MONOCYTES; ORPHAN NUCLEAR RECEPTORS; PLAQUE, ATHEROSCLEROTIC; REACTIVE OXYGEN SPECIES; SCAVENGER RECEPTORS, CLASS A;

EID: 84959463849     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1243     Document Type: Article

References (55)

1. Hansson, G. K. and Hermansson, A. (2011) The immune system in atherosclerosis. Nat. Immunol. 12, 204-212.
2. Leitinger, N. and Schulman, I. G. (2013) Phenotypic polarization of macrophages in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 33, 1120-1126.
3. Stoger, J. L., Gijbels, M. J., van der Velden, S., Manca, M., van der Loos, C. M., et al. (2012) Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225, 461-468.
4. Hoeksema, M. A., Stoger, J. L., and de Winther, M. P. (2012) Molecular pathways regulating macrophage polarization: implications for atherosclerosis. Curr. Atheroscler. Rep. 14, 254-263.
5. Moore, K. J. and Tabas, I. (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355.
6. Glass, C. K. and Witztum, J. L. (2001) Atherosclerosis: the road ahead. Cell 104, 503-516.
7. Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., et al. (2011) Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ. Res. 108, 985-995.
8. Spann, N. J., Garmire, L. X., McDonald, J. G., Myers, D. S., Milne, S. B., et al. (2012) Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151, 138-152.
9. Tontonoz, P. and Mangelsdorf, D. J. (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17, 985-993.
10. Repa, J. J., Turley, S. D., Lobaccaro, J. A., Medina, J., Li, L., et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529.
11. Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., et al. (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97, 12097-12102.
12. Costet, P., Luo, Y., Wang, N., and Tall, A. R. (2000) Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275, 28240-28245.
13. Meurs, I., Van Eck, M., and Van Berkel, T. J. (2010) High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis. Curr. Pharm. Des. 16, 1445-1467.
14. Gargiulo, S., Sottero, B., Gamba, P., Chiarpotto, E., Poli, G., et al. (2011) Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: implications regarding the vulnerability of atherosclerotic lesions. Free Radic. Biol. Med. 51, 844-855.
15. Bellora, F., Castriconi, R., Dondero, A., Reggiardo, G., Moretta, L., et al. (2010) The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc. Natl. Acad. Sci. USA 107, 21659-21664.
16. Kock, R., Delvoux, B., and Greiling, H. (1997) Determination of total cholesterol in serum by liquid chromatography-isotope dilution mass spectrometry. Clin. Chem. 43, 1896-1903.
17. Domenicotti, C., Marengo, B., Verzola, D., Garibotto, G., Traverso, N., et al. (2003) Role of PKC-delta activity in glutathione-depleted neuroblastoma cells. Free Radic. Biol. Med. 35, 504-516.
18. Furfaro, A. L., Macay, J. R., Marengo, B., Nitti, M., Parodi, A., et al. (2012) Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1. Free Radic. Biol. Med. 52, 488-496.
19. Heussen, C. and Dowdle, E. B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202.
20. Marengo, B., De Ciucis, C. G., Ricciarelli, R., Furfaro, A. L., Colla, R., et al. (2013) p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment. Cell Death Dis. 4, e589.
21. Marengo, B., De Ciucis, C., Ricciarelli, R., Passalacqua, M., Nitti, M., et al. (2011) PKCdelta sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage. PLoS One 6, e14661.
22. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
23. Rader, D. J. and Pure, E. (2005) Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab. 1, 223-230.
24. Nagase, H., Visse, R., and Murphy, G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562-573.
25. Lee, S. J., Seo, K. W., Yun, M. R., Bae, S. S., Lee, W. S., et al. (2008) 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways. Free Radic. Biol. Med. 45, 1487-1492.
26. Leonarduzzi, G., Gamba, P., Gargiulo, S., Biasi, F., and Poli, G. (2012) Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic. Biol. Med. 52, 19-34.
27. Shibata, N. and Glass, C. K. (2010) Macrophages, oxysterols and atherosclerosis. Circ. J. 74, 2045-2051.
28. Manning-Tobin, J. J., Moore, K. J., Seimon, T. A., Bell, S. A., Sharuk, M., et al. (2009) Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 29, 19-26.
29. Zhang, F., Liu, H., Jiang, G., Wang, H., Wang, X., et al. (2015) Changes in the proteomic profile during the differential polarization status of the human monocyte-derived macrophage THP-1 cell line. Proteomics 15, 773-786.
30. Mantovani, A., Sica, A., and Locati, M. (2005) Macrophage polarization comes of age. Immunity 23, 344-346.
31. Biasi, F., Leonarduzzi, G., Vizio, B., Zanetti, D., Sevanian, A., et al. (2004) Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. Faseb J. 18, 693-695.
32. Mantovani, A., Garlanda, C., and Locati, M. (2009) Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 29, 1419-1423.
33. Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., et al. (1999) Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85, e17-e24.
34. Potteaux, S., Esposito, B., van Oostrom, O., Brun, V., Ardouin, P., et al. (2004) Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 24, 1474-1478.
35. Von Der Thusen, J. H., Kuiper, J., Fekkes, M. L., De Vos, P., Van Berkel, T. J., et al. (2001) Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. Faseb J. 15, 2730-2732.
36. Halvorsen, B., Waehre, T., Scholz, H., Clausen, O. P., von der Thusen, J. H., et al. (2005) Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J. Lipid Res. 46, 211-219.
37. Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., et al. (2002) Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90, 1064-1071.
38. Komohara, Y., Ohnishi, K., Kuratsu, J., and Takeya, M. (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 216, 15-24.
39. Melton, D. W., McManus, L. M., Gelfond, J. A., and Shireman, P. K. (2015) Temporal phenotypic features distinguish polarized macrophages in vitro. Autoimmunity 48, 161-176.
40. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596.
41. Burger, J. A. and Kipps, T. J. (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761-1767.
42. Calkin, A. C. and Tontonoz, P. (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13, 213-224.
43. Buono, C., Li, Y., Waldo, S. W., and Kruth, H. S. (2007) Liver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL. J. Lipid Res. 48, 2411-2418.
44. Zelcer, N., Hong, C., Boyadjian, R., and Tontonoz, P. (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325, 100-104.
45. Ma, L., Dong, F., Zaid, M., Kumar, A., and Zha, X. (2012) ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation. J. Biol. Chem. 287, 40502-40512.
46. Fowler, A. J., Sheu, M. Y., Schmuth, M., Kao, J., Fluhr, J. W., et al. (2003) Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J. Invest. Dermatol. 120, 246-255.
47. Buttari, B., Segoni, L., Profumo, E., D'Arcangelo, D., Rossi, S., et al. (2013) 7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages. Biochem. Pharmacol. 86, 130-137.
48. Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., et al. (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA 96, 266-271.
49. Bensinger, S. J. and Tontonoz, P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470-477.
50. Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., et al. (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134, 97-111.
51. Berrodin, T. J., Shen, Q., Quinet, E. M., Yudt, M. R., Freedman, L. P., et al. (2010) Identification of 5alpha, 6alpha-epoxycholesterol as a novel modulator of liver X receptor activity. Mol. Pharmacol. 78, 1046-1058.
52. Blom, T., Back, N., Mutka, A. L., Bittman, R., Li, Z., et al. (2010) FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. Circ. Res. 106, 720-729.
53. Zhang, J. R., Coleman, T., Langmade, S. J., Scherrer, D. E., Lane, L., et al. (2008) Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J. Clin. Invest. 118, 2281-2290.
54. Umetani, M., Ghosh, P., Ishikawa, T., Umetani, J., Ahmed, M., et al. (2014) The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Cell Metab. 20, 172-182.
55. Ghisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M. E., et al. (2007) Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25, 57-70.